ECZADERM 0.1% CREAM 30G

Indications

Approved Uses

Relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses (e.g., atopic dermatitis/eczema, contact dermatitis, psoriasis).

Dosage & Administration

Dosing by Condition

For corticosteroid-responsive dermatoses (including eczema/atopic dermatitis, contact dermatitis, psoriasis): apply a thin layer to affected areas once daily; reassess if no improvement within ~2 weeks and avoid routine occlusion unless specifically directed for resistant plaques.

Initial Dose

Apply a thin film to the affected skin areas once daily.

Maintenance Dose

Apply a thin film to the affected skin areas once daily. Therapy should be discontinued when control is achieved.

Maximum Dose

Apply a thin layer once daily; use the lowest effective amount and avoid prolonged continuous use (generally reassess if no improvement within ~2 weeks; do not continue beyond 2-3 weeks without medical review).

Children's Dosage

Children ≥2 years: Apply thin layer once daily for up to 3 weeks; not recommended in children under 2 years; use minimum effective amount and avoid prolonged use

Dose Adjustment Notes

Once control is achieved, taper by reducing frequency (e.g., every other day then 2 times weekly) and discontinue when possible; avoid prolonged continuous use, especially on face/flexures or under occlusion; in children use the lowest effective amount for the shortest duration and avoid diapers/occlusion.

How to Take

For topical use only: apply a thin layer to affected skin once daily and rub in gently; wash hands before and after use (after only if hands are not the treated area); avoid eyes, mouth, and other mucous membranes; do not use on face/groin/axillae or under occlusion/tight dressings unless directed; use the smallest amount for the shortest duration.

Side Effects

Common Side Effects

Application-site burning/stinging, pruritus (itching), dryness, irritation/erythema; folliculitis; acneiform eruption; hypopigmentation; perioral dermatitis; allergic contact dermatitis; secondary infection; with prolonged/large-area/occlusive use: skin atrophy, striae, telangiectasia, hypertrichosis; rare/serious: HPA-axis suppression/Cushingoid effects, hyperglycemia, and ocular effects (e.g., glaucoma/cataract) especially with periocular use.

Side Effect Frequency

Common: application-site burning/stinging, pruritus (itching), dryness, irritation/erythema; Uncommon: folliculitis, acneiform eruption, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infection; With prolonged/large-area/occlusive use: skin atrophy, striae, telangiectasia, hypertrichosis; Rare/serious: HPA-axis suppression/Cushingoid effects, hyperglycemia, and ocular effects (e.g., glaucoma/cataract) especially with periocular use.

Safety & Warnings

Contraindications

Hypersensitivity to mometasone furoate or any excipients; untreated bacterial, viral (e.g., herpes simplex/varicella), fungal or parasitic skin infections; rosacea; perioral dermatitis.

Warnings & Precautions

Avoid eyes/mucosa; do not use on untreated infections-treat infection first/with appropriate antimicrobial; avoid large areas, occlusion, and prolonged use (higher risk in children); stop and reassess if irritation/sensitization occurs; avoid use on broken/ulcerated skin; consider tapering after prolonged use to prevent rebound.

Age Restriction

Not recommended for children under 2 years unless specifically directed by a specialist.

Drug Interactions

Food Interaction

No clinically relevant food interactions (not applicable for topical administration).

Special Populations

Children

Children ≥2 years: Apply thin layer once daily for up to 3 weeks; not recommended in children under 2 years; use minimum effective amount and avoid prolonged use

Kidney Impairment

No adjustment needed

Storage & Patient Advice

Stopping the Medicine

If used for prolonged periods or on large areas/under occlusion, taper by reducing frequency/potency rather than stopping abruptly; short courses can usually be stopped without taper.

Overdose

Excessive/prolonged topical use (especially large areas/occlusion) may cause local atrophy and systemic effects including HPA-axis suppression/Cushingoid features; accidental ingestion is usually low risk but warrants medical advice/poison center contact if significant amount or symptoms occur.

Patient Counseling

Apply a thin layer to affected skin once daily as prescribed; use the smallest amount for the shortest duration and stop when controlled; avoid eyes and do not use on face/groin/axillae unless directed; do not occlude/bandage unless instructed; wash hands after application; do not apply to infected/broken skin unless treated/approved; seek medical review if not improved within ~2 weeks or if signs of skin atrophy/striae or other steroid adverse effects occur.

Monitoring Requirements

Short courses on limited areas: no routine labs; monitor clinically for local adverse effects (atrophy, striae, irritation) and infection; with prolonged use, large surface area, occlusion, pediatric use, or use on thin skin: periodically assess for HPA-axis suppression and growth effects in children as clinically indicated.

Pharmacology

Half-Life

Not well established for topical use; a definitive elimination half‑life after topical application is generally not provided/clinically relied upon.

Product Information

Available Dosage Forms

Cream (this product: 0.1% topical cream in a 30 g tube).

Composition per Dose

Each gram of cream: 1 mg mometasone furoate (0.1% w/w) in a cream base

Generic Availability

Yes

OTC Alternatives

Hydrocortisone 1% cream/ointment (OTC, low‑potency topical corticosteroid) and regular emollients/moisturizers as supportive care for xerosis/eczema symptoms (where appropriate).

Skin Condition

Eczema, Psoriasis, Dermatitis

Steroid Potency

Potent

Legal Disclaimer - Al Mujtama Pharmacy

The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.

Al Mujtama Pharmacy assumes no legal or medical liability for:

• Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
• Any discrepancy between the information provided and the product's package insert or SFDA guidelines
• Any misuse of medication resulting from personal interpretation of the content displayed

Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.

By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.

Your health is a trust - always consult your doctor first.